Choose Language
Select a language for news translation.
Dr. Oz’s GLP-1 Bridge costs $750/month, 25% cheaper than competitors, but experts warn temporary discounts could discourage future drug innovation. High U.S. l…
A daily oral GLP-1 pill (orforglipron) led to 11.9% weight loss over 36 weeks, matching injectable options like Wegovy. This pill could expand treatment access…
A North Carolina grandmother killed her six-month-old granddaughter by giving her prescription mood disorder drugs, receiving 14–17 months in prison for involu…
CVS now offers GLP-1 weight-loss drugs via 9,000 pharmacies with $49 virtual visits, low-cost pricing, and free coaching, addressing prescription barriers and …
Eli Lilly’s stock hit a record high after Europe endorsed its leukemia drug Jaypirca and Medicare agreed to cover its weight-loss drugs Zepbound and Mounjaro, …
Researchers at MIT cured a lab-grown "vagina on a chip" infected with gonorrhea using an AI-discovered antibiotic, demonstrating AI's potential to rapidly find…
Carter Faith and Wyatt Flores released the duet "Nothin' Better to Do," blending country, rock, and raw storytelling. This collaboration highlights Faith's pus…
Record levels of synthetic drugs, cocaine, and methamphetamine are flooding global markets due to traffickers exploiting instability and weak borders, posing g…
GLP-1 drugs like Ozempic and Wegovy help average 15% fat loss, but up to 30% see less than 5% weight loss after six months; poor sleep, medications, and geneti…
Fluctuating oestrogen levels during the menstrual cycle increase brain drug delivery by up to 50% in female mice, suggesting dosing precision may need adjustme…
Insurers are dropping coverage for weight-loss drugs like Zepbound and Wegovy due to high costs, leaving 24 million Americans without access by 2026. Coverage …
